Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MePhaCard: R-methadone Switch Study
NCT04254731Phase 4Active, not recruiting
- Sponsor
- Oslo University Hospital
- Start
- May 2015
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of levomethadone in opioid use disorder (OUD), sponsored by Oslo University Hospital. Primary endpoints: Effects of switching from racemic methadone to R-methadone on serum methadone concentrations, Effects of switching from racemic methadone to R-methadone on QTc interval and 2 more. Started May 2015; status: active, not recruiting.
02
Drugs
levomethadone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04254731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04254731.